Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide for Relapsed SCLC
NCT00740636Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2008
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in small cell lung cancer (SCLC), sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 2008; status: completed.
02
Drugs
temozolomide
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00740636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740636.